A short modular synthesis has been developed to produce the psychoactive substance ibogaine and related compounds.1 The approach could help to reduce dependency on natural plant sources for these products and generate new compounds with potential applications in the treatment of drug addiction and depression.
‘Anecdotal reports and some open-label clinical trials have suggested that ibogaine has profound anti-addictive and anti-depressant properties ...
Ibogaine by David Dardashti, a leading provider of ibogaine treatment for addiction, today announced a groundbreaking initiative that combines cutting-edge therapy with transformative travel experiences. The company is now offering clients the opportunity to participate in fully-funded therapeutic adventures to breathtaking destinations in Mexico, including Isla Mujeres, Cozumel, ...
The research would investigate ibogaine's potential to treat neurological disorders such as traumatic brain injuries and post-traumatic stress …
PHOENIX — Arizona lawmakers are moving forward with a bill that would fund clinical trials of a psychedelic drug that could help veterans.
House Bill 2871 would appropriate $5 million to fund clinical trials that investigate the medical uses of ibogaine, a substance that could potentially treat traumatic brain injuries and other conditions, such as Parkinson’s Disease and Alzheimer’s.
This could help the drug ...
In addition to iboga and ibogaine, Forynja and Björnsdóttir say they are also interested in the implementation of MDMA-assisted therapy for patients …